- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 30, 2026 | 45.87M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 45.69M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 45.73M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 46.9M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 47.23M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $64.46M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $121.45M |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $21.22M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $23.44M |
| Capex | Q2 2026 · Mar 31, 2026 | $17.65M |
| Capex restated | Q2 2026 · Mar 31, 2025 | $25.94M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $1.39B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $1.4B |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $8.02M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $8.03M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $109.67M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $99.05M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $94.45M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $108.9M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $73.97M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $214.74M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $227.78M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $224.89M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $429.62M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $446.19M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $1.97B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.23B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $1.25B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $2.07B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $2.08B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.42 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $1.83 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $1.21 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.70 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.43 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $1.88 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $1.24 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.80 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $104.64M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $213.96M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $107.46M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $214.51M |
| Net Income | Q2 2026 · Mar 31, 2026 | $19.32M |
| Net Income | Q2 2026 · Mar 31, 2026 | $83.71M |
| Net Income | Q2 2026 · Dec 31, 2025 | $64.39M |
| Net Income | Q2 2026 · Mar 31, 2025 | $56.76M |
| Net Income | Q2 2026 · Mar 31, 2025 | $127.61M |
| Net Income | Q2 2026 · Dec 31, 2024 | $70.85M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $87.35M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $186.76M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $90.89M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $195.23M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $191.99M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $400.72M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $198.35M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $409.73M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $229.87M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $475.4M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $228.34M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $460.4M |
| Revenue | Q2 2026 · Mar 31, 2026 | $421.86M |
| Revenue | Q2 2026 · Mar 31, 2026 | $876.12M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $426.68M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $870.14M |